Physician profile
Heather N Hambrick
NPI 1780705434
$4,351.65
in general payments reported to CMS, 2019-2025
19 companies · $861 in 2025
The $861 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $636 · 2022: $559 · 2023: $889 · 2024: $1,406 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,156.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,821.88 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Collegium Pharmaceutical, INC. | $1,313.76 | 2021-2025 | Belbuca, Xtampza, Nucynta |
| Nevro Corp. | $258.44 | 2021-2024 | Senza |
| Tersera Therapeutics LLC | $243.97 | 2021-2025 | Prialt |
| Abbvie INC. | $181.89 | 2021-2024 | |
| Boston Scientific Corporation | $111.63 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $100.39 | 2023-2025 | Ztlido |
| Biohaven Pharmaceuticals, INC. | $83.94 | 2021 | |
| Spr Therapeutics, INC | $42.66 | 2025 | Sprint Pns System |
| Uswm, LLC | $26.32 | 2023 | Lucemyra, Zimhi |
| Biodelivery Sciences International, INC. | $25.28 | 2021 | |
| Pfizer INC. | $23.91 | 2021 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.83 | 2025 | |
| Almatica Pharma LLC | $18.34 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $16.61 | 2023 | Stimrouter Implantable Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $16.17 | 2022 | |
| Ibsa Pharma INC. | $14.65 | 2023 | Tirosint, Licart |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Hambrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.